99 related articles for article (PubMed ID: 18973255)
1. Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2.
Amboni M; Pellecchia MT; Cozzolino A; Picillo M; Vitale C; Barone P; Varrone A; Garavaglia B; Gambelli S; Federico A
Mov Disord; 2009 Jan; 24(2):303-5. PubMed ID: 18973255
[No Abstract] [Full Text] [Related]
2. Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study.
Pellecchia MT; Varrone A; Annesi G; Amboni M; Cicarelli G; Sansone V; Annesi F; Rocca FE; Vitale C; Pappatà S; Quattrone A; Barone P
Mov Disord; 2007 Mar; 22(4):559-63. PubMed ID: 17149727
[TBL] [Abstract][Full Text] [Related]
3. Neurodegenerative Parkinsonism and progressive external ophthalmoplegia with a Twinkle mutation.
Vandenberghe W; Van Laere K; Debruyne F; Van Broeckhoven C; Van Goethem G
Mov Disord; 2009 Jan; 24(2):308-9. PubMed ID: 18973250
[No Abstract] [Full Text] [Related]
4. Ptosis as a feature of late-onset glycogenosis type II.
Ravaglia S; Repetto A; De Filippi P; Danesino C
Neurology; 2007 Jul; 69(1):116; author reply 116. PubMed ID: 17606892
[No Abstract] [Full Text] [Related]
5. Subclinical cortical reorganization: a preclinical imaging marker for recessively inherited PD?
Zhang L
Neurology; 2009 Mar; 72(12):1036-7. PubMed ID: 19307537
[No Abstract] [Full Text] [Related]
6. A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations.
Ribeiro MJ; Thobois S; Lohmann E; du Montcel ST; Lesage S; Pelissolo A; Dubois B; Mallet L; Pollak P; Agid Y; Broussolle E; Brice A; Remy P;
J Nucl Med; 2009 Aug; 50(8):1244-50. PubMed ID: 19617340
[TBL] [Abstract][Full Text] [Related]
7. Clinical Reasoning: A 58-year-old man with progressive ptosis and walking difficulty.
Kuo PH; Lo RY; Tanji K; Kuo SH
Neurology; 2017 Jul; 89(1):e1-e5. PubMed ID: 28674165
[No Abstract] [Full Text] [Related]
8. Marked diurnal fluctuation and rest benefit in a patient with parkin mutation.
Chung SJ; Park HK; Ki CS; Kim MJ; Lee MC
Mov Disord; 2008 Mar; 23(4):624-6. PubMed ID: 18228570
[No Abstract] [Full Text] [Related]
9. [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
Pal PK; Leung J; Hedrich K; Samii A; Lieberman A; Nausieda PA; Calne DB; Breakefield XO; Klein C; Stoessl AJ
Mov Disord; 2002 Jul; 17(4):789-94. PubMed ID: 12210877
[TBL] [Abstract][Full Text] [Related]
10. Clinical Reasoning: A demure teenager and her dystonic foot.
Cullinane PW; Browne P; Hennessy MJ; Counihan TJ
Neurology; 2017 Aug; 89(7):e71-e75. PubMed ID: 28808173
[No Abstract] [Full Text] [Related]
11. Parkin-related disease clinically diagnosed as a pallido-pyramidal syndrome.
Wickremaratchi MM; Majounie E; Morris HR; Williams NM; Lewis H; Gill SS; Khan S; Heywood P; Hardy J; Wiles CM; Singleton AB; Quinn NP
Mov Disord; 2009 Jan; 24(1):138-40. PubMed ID: 18942080
[No Abstract] [Full Text] [Related]
12. Expanding phenotype and clinical heterogeneity in patients with identical mutation of the parkin gene.
Kunishige M; Mitsui T; Kuroda Y; Yoshida S; Kosaka M; Matsumoto T
Eur Neurol; 2004; 51(3):183-5. PubMed ID: 15073448
[No Abstract] [Full Text] [Related]
13. Comparative genomic hybridization solves a 14-year-old PARKIN mystery.
Schüle B; Hatchwell E; Eis PS; Langston JW
Ann Neurol; 2015 Oct; 78(4):663-4. PubMed ID: 26179350
[No Abstract] [Full Text] [Related]
14. Images in neuroscience. Neuroimaging, XII. SPECT imaging of dopamine nerve terminals.
Seibyl JP; Marek K; Innis RB
Am J Psychiatry; 1996 Sep; 153(9):1131. PubMed ID: 8780413
[No Abstract] [Full Text] [Related]
15. Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism.
Kim JY; Kim SY; Kim JM; Kim YK; Yoon KY; Kim JY; Lee BC; Kim JS; Paek SH; Park SS; Kim SE; Jeon BS
Neurology; 2009 Apr; 72(16):1385-9. PubMed ID: 19380697
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms of Diaphragm Myopathy in Humans With Severe Heart Failure.
Mangner N; Garbade J; Heyne E; van den Berg M; Winzer EB; Hommel J; Sandri M; Jozwiak-Nozdrzykowska J; Meyer AL; Lehmann S; Schmitz C; Malfatti E; Schwarzer M; Ottenheijm CAC; Bowen TS; Linke A; Adams V
Circ Res; 2021 Mar; 128(6):706-719. PubMed ID: 33535772
[TBL] [Abstract][Full Text] [Related]
17. Heterozygous exon 3 deletion in the Parkin gene in a patient with clinical and radiological MSA-C phenotype.
Barsottini OG; Felício AC; de Carvalho Aguiar P; Godeiro-Junior C; Pedroso JL; de Aquino CC; Bor-Seng-Shu E; de Andrade LA
Clin Neurol Neurosurg; 2011 Jun; 113(5):404-6. PubMed ID: 21183274
[No Abstract] [Full Text] [Related]
18. Roll on genetics of PARK and Parkinsonism in the developing world.
Kalaria RN; Akinyemi R
J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):128. PubMed ID: 20145023
[No Abstract] [Full Text] [Related]
19. PARK2 presenting as a disabling peripheral axonal neuropathy.
Domingos J; Coelho T; Taipa R; Basto JP; Melo-Pires M; Magalhães MJ
Neurol Sci; 2015 Feb; 36(2):341-3. PubMed ID: 25060649
[No Abstract] [Full Text] [Related]
20. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.
Hilker R; Klein C; Ghaemi M; Kis B; Strotmann T; Ozelius LJ; Lenz O; Vieregge P; Herholz K; Heiss WD; Pramstaller PP
Ann Neurol; 2001 Mar; 49(3):367-76. PubMed ID: 11261512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
